Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

[email protected]

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal has submitted to BSE the Shareholding Pattern f...

20-Jul-2026|3:50PM

As of June 2026, 68.85% is owned by Indian Promoters and 31.15% by Public.

Hikal - Certificate under SEBI (Depositories and Part...

09-Jul-2026|3:39PM

Hikal Limited has informed the Exchange about Certificate under SEBI (Depos

Hikal - Compliances-Certificate under Reg. 74 (5) of ...

09-Jul-2026|3:31PM

Certificate under Regulation 74(5) of the Securities and Exchange Board of

Hikal - Shareholders meeting

06-Jul-2026|5:45PM

Hikal Limited has submitted the Exchange a copy Srutinizers report of Post

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.50219.75
Aarti Drug404.503,691.87
Aarti Pharma673.806,110.01
Abbott India28,005.0059,508.67
Accent Micro494.951,187.34
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..88.551.34
Tata Sm..73.060.58
Motilal..0.020.05
Bandhan..0.010.05
Motilal..0.000.00
More

Board Meetings

DatePurpose
27/05/2026Audited Results & F..
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
More